Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | Pandemic brought new attention to preprints |
|
| 2 | News media outlets vary widely in how they cover preprint studies |
|
| 3 | Health workers worried about travelling as mutated Covid-19 strain is in circulation |
|
| 4 | Study Explores Which Healthcare Workers Are Apprehensive of a COVID-19 Vaccine |
|
| 5 | Novel SARS CoV-2 Saliva Collection Devices Address COVID-19 Testing Challenges, Improving Lab Efficiency and PCR Test Performance |
|
| 6 | Traitorous COVID antibodies and fast-spreading variant News Round-Up |
|
| 7 | COVID reinfections are unusual — but could still help the virus to spread |
|
| 8 | Even Patients With Cancer in Remission at Risk for Severe COVID |
|
| 9 | Accelerating vaccine rollout may provide greatest reduction in COVID-19 mortality |
|
| 10 | Largest global study of 'long Covid' finds many patients unable to return to work six months later |
|
| 11 | Hyperinflammatory conditions drive gender differences in COVID-19 severity and mortality |
|
| 12 | Media outlets inconsistently mention uncertain status of COVID-19 preprints |
|
| 13 | Wearable heart monitors and deep learning can provide early warning of SARS-CoV-2 infection |
|
| 14 | N501Y mutation may be associated with higher viral load, says preliminary study |
|
| 15 | California virus variant driving surge around LA; smell training advised for lingering problem |
|
| 16 | Electrospun Nanofibrous Filters Could Protect Against Coronavirus Particles |
|
| 17 | Is one-dose COVID-19 vaccination better than two? |
|
| 18 | Rapid reopening crucial in promoting the second wave of COVID-19 |
|
| 19 | Nearly one third of UK's hospitalized COVID-19 patients readmitted |
|
| 20 | What scientific papers on Bharat Biotech's Covaxin say |
|
| 21 | Can the onset and end of an epidemic be predicted? A SARS-CoV-2 modeling case study |
|
| 22 | Long-Term Neurologic Symptoms Emerge in COVID-19 |
|
| 23 | Re: Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data |
|
| 24 | WebMD Fatigue, Brain Fog Most Common in 'Long COVID' |
|
| 25 | New COVID-19 variant found in more than one-third of Cedars-Sinai patients, new study shows |
|
| 26 | How the coronavirus is changing science: Research is moving fast with medRxiv and other tools |
|
| 27 | Re: Covid-19: What is happening with the vaccine rollout? |
|
| 28 | Saliva-based tests as accurate as nasopharyngeal swabs for COVID-19 diagnosis |
|
| 29 | Approximately a third of COVID-19 infections are asymptomatic |
|
| 30 | COVID-19 is dangerous for middle-aged adults, not just the elderly: Study examines infection fatality rates for COVID-19 |
|
| 31 | Estimation of COVID-19 risk-stratified epidemiological parameters and policy implications for Los Angeles County through an integrated risk and stochastic epidemiological model |
|
| 32 | Patients, clinicians seek answers to the mystery of 'Long COVID' |
|
| 33 | UK variant linked to high viral loads, Neanderthal gene offers protection |
|
| 34 | UK COVID-19 death to case ratio increased in December 2020, say researchers |
|
| 35 | How swamped preprint servers are blocking bad coronavirus research |
|
| 36 | Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients |
|
| 37 | Preprint server founded by Yale now leading source for COVID-19 discoveries |
|
| 38 | Even When Cancer Is in Remission, Patients' Risks of Severe COVID Rise |
|
| 39 | Oxford Immunotec's (OXFD) T-SPOT Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva's VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study |
|
| 40 | Study shows durable specific humoral immunity against SARS-CoV-2 after mild or asymptomatic infection |
|
| 41 | New COVID-19 test gives positive result in just a few minutes |
|
| 42 | Accurate COVID-19 test results in only five minutes |
|
| 43 | Could Ivermectin be an effective antiviral against SARS-CoV-2? |
|
| 44 | Researchers claim SARS-CoV-2 B.1.1.7 variant likely to become globally dominant |
|
| 45 | Bleeding disorder linked to poor clinical outcomes in COVID-19 patients |
|
| 46 | European soccer players may have up to 3.5 times higher risk for COVID-19 |
|
| 47 | The Problem With Preprints in Clinical Science |
|
| 48 | Prophylaxis for COVID-19: a systematic review |
|
| 49 | BioNano Genomics, Inc. (BNGO) Announces MD Anderson Cancer Center Publication Shows How its Saphyr System Can Significantly Reduce Time to Actionable Results for Myelodysplastic Syndrome Patients |
|
| 50 | Circulating antiphospholipid antibodies drive endothelial cell activation in COVID-19 |
|
| 51 | Antibodies and inflammatory markers are pervasive in colostrum of SARS-CoV-2 infected women |
|
| 52 | Think again |
|
| 53 | Endothelial tissue injury significantly contributes to ARDS in COVID-19 patients, finds study |
|
| 54 | Mapping antibody reactivity in COVID-19 patients by using multi-coronavirus protein microarray |
|
| 55 | Anti-COVID diet? |
|
| 56 | Metformin use reduces risk of death for patients with COVID-19 and diabetes |
|
| 57 | How to bring preprints to the charged field of medicine |
|
| 58 | Enlivex Announces Pre-Print Publication of Full Results from Phase Ib Severe Sepsis Trial on medRxiv |
|
| 59 | Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis |
|
| 60 | Study hints that supplements may reduce COVID-19 risk in females |
|
| 61 | Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study |
|
| 62 | Daily briefing: medRxiv brings preprints to medical science |
|
| 63 | How do SARS-CoV-2 antibodies change over time in recovered patients? |
|
| 64 | MedRxiv: The Research Revolution Will Not Be Peer Reviewed |
|
| 65 | Banner Health has started using an arthritis drug on some critically ill COVID-19 patients |
|
| 66 | The Proportion of SARS-CoV-2 Infections That Are Asymptomatic : A Systematic Review |
|
| 67 | UPDATE 1-Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients |
|
| 68 | Deep RNA Sequencing of Intensive Care Unit Patients with COVID-19 |
|
| 69 | Real-Time Electronic Health Record Mortality Prediction During the COVID-19 Pandemic: A Prospective Cohort Study |
|
| 70 | Angiopoietin-2 is a crucial determinant of COVID-19 prognosis, study finds |
|
| 71 | Danish study suggests local lockdown had no effect on SARS-CoV-2 infection rate |
|
| 72 | medRxiv to PLOS: Direct preprint transfers |
|
| 73 | Vitamin D and COVID-19: why the controversy? |
|
| 74 | High factor V levels linked to lymphopenia and weakened immunity in severe COVID-19 |
|
| 75 | Optimizing vaccine allocation for COVID-19 vaccines: critical role of single-dose vaccination |
|
| 76 | Coronavirus Vaccine Updates: From Pfizer to Moderna to Sputnik, a look at major COVID vaccine candidates and their status |
|
| 77 | Coronavirus Tests Science’s Need for Speed Limits |
|
| 78 | Largest-to-Date COVID Mortality Study Released |
|
| 79 | Middle-aged face greater risk of dying from Covid-19 than from accident: Study |
|
| 80 | How coronavirus variants may pose challenges for COVID-19 vaccines |
|
| 81 | Low acceptance of COVID-19 vaccine among healthcare workers in USA |
|
| 82 | Coronavirus: Neanderthal gene could protect against COVID-19 |
|
| 83 | What are the SARS-CoV-2 exposure risks for workers on mink farms? |
|
| 84 | Waiting for the vaccine in 2021: Where exactly do we stand? |
|
| 85 | Can metabolic biomarkers help clinicians stratify adverse outcome risk in COVID-19 patients? |
|
| 86 | Covering research preprints amid the coronavirus: 6 things to know |
|
| 87 | Strong caveats are lacking as news stories trumpet preliminary COVID-19 research | |
|
| 88 | Medical preprint server debuts |
|
| 89 | HighWire Supports CSHL, BMJ and Yale to Launch medRxiv |
|
| 90 | How a torrent of COVID science changed research publishing — in seven charts |
|
| 91 | Jeffrey Aronson: When I Use a Word . . . Withdrawn |
|
| 92 | A Pandemic Moves Peer Review to Twitter |
|
| 93 | Death of volunteer who took dose of Covaxin 'not related' to vaccine or placebo, says Bharat Biotech |
|
| 94 | ACE2 and furin levels linked to inflammation in smokers with COVID-19 |
|
| 95 | Related: Pandemic puts preprints first |
|
| 96 | Panel offers look at open access in the COVID-19 era | Cornell Chronicle |
|
| 97 | Study: Female Healthcare Workers Are Experiencing COVID-19 Burnout at High Rates |
|
| 98 | New test detects SARS-CoV-2 in less than 5 mins |
|
| 99 | What are the key factors and impact of interventions in England’s COVID-19 epidemic? |
|
| 100 | Higher prevalence of SARS-CoV-2 with D614G mutation in Washington State |
|